Tscan Therapeutics Overview
Tscan Therapeutics Discounted Cash Flow
DCF Analysis for TCRX.
Get informed when a big investor buys or sells
+ FollowFair Value
$-1.58
Current Fair Value
$-1.58
↓ 271.6% Downside
Overvalued by 271.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison